Clinical Trial

CanCan Body Composition Study

Study acronym: Cancan
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2025 (before its estimated April 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to develop a dataset with reference body composition measurements using criterion methods. This dataset will be used to develop new protocols to study patients with cancer. Obtaining measurements of sodium bromide (NaBr), deuterium dilution (D2O), and D3-Creatine in a stratified sample of adults will determine the accuracy (and precision) of the available devices for ECW, TBW, and skeletal muscle mass measurements.
Trial Details
NCT Number NCT07305753
Lead Sponsor Pennington Biomedical Research Center
Conditions Healthy Participants, Young Healthy Adults, Elderly (People Aged 65 or More)
Enrollment 40 participants
Start Date 2025-10-15
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-26